|
Re: Share Price is IRRELEVANT
|
6
|
Resverlogix Corp.
|
Apr 06, 2019 10:15AM
|
|
The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
|
6
|
Resverlogix Corp.
|
Dec 21, 2021 04:47PM
|
|
Re: China- 1 Million daily COVID cases
|
6
|
Resverlogix Corp.
|
Dec 27, 2022 10:00AM
|
|
Re: One week later....
|
6
|
Resverlogix Corp.
|
May 20, 2021 09:55AM
|
|
where's the bone & when?
|
6
|
Resverlogix Corp.
|
Jan 05, 2021 01:17PM
|
|
Re: Wow! We need RVX stock buyers instead of warrant buyers
|
6
|
Resverlogix Corp.
|
Sep 24, 2019 12:56PM
|
|
Re: I am hoping...
|
6
|
Resverlogix Corp.
|
Oct 09, 2019 01:59PM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
6
|
Resverlogix Corp.
|
Jan 05, 2022 12:44PM
|
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
6
|
Resverlogix Corp.
|
Nov 30, 2021 12:45PM
|
|
Re: Financials
|
6
|
Resverlogix Corp.
|
Sep 12, 2020 12:10PM
|
|
when is it consider a BIG problem?
|
6
|
Resverlogix Corp.
|
Sep 28, 2021 01:04PM
|
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
6
|
Resverlogix Corp.
|
Mar 28, 2022 02:58PM
|
|
well according to HQ/Sarah we have been kept in loop all along....
|
6
|
Resverlogix Corp.
|
May 17, 2022 09:10AM
|
|
Re: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine
|
6
|
Resverlogix Corp.
|
Mar 18, 2022 01:34PM
|
|
Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
|
6
|
Resverlogix Corp.
|
Mar 26, 2020 02:53PM
|
|
Re: Saudi
|
6
|
Resverlogix Corp.
|
Jan 15, 2021 11:54AM
|
|
Re: Covid 19 trial
|
6
|
Resverlogix Corp.
|
Jun 04, 2021 11:32AM
|
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
6
|
Resverlogix Corp.
|
Oct 26, 2023 12:50PM
|
|
GV on stock house
|
6
|
Resverlogix Corp.
|
Apr 08, 2021 11:18AM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
6
|
Resverlogix Corp.
|
Apr 14, 2021 10:45PM
|
